Publication
Personalised medicine for Familial Hypercholesterolemia – pilot study
| dc.contributor.author | Chora, Joana Rita | |
| dc.contributor.author | Bourbon, Mafalda | |
| dc.date.accessioned | 2022-07-08T17:29:44Z | |
| dc.date.available | 2022-07-08T17:29:44Z | |
| dc.date.issued | 2021-05 | |
| dc.description.abstract | Familial Hypercholesterolemia (FH) confers a high risk for cardiovascular disease (CVD) with several modulating characteristics, which makes it the perfect candidate for personalised medicine approaches. | pt_PT |
| dc.description.sponsorship | With thanks to the EAS for support in the form of a Young Investigator Fellowship | pt_PT |
| dc.description.version | N/A | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.18/8114 | |
| dc.language.iso | eng | pt_PT |
| dc.publisher | Instituto Nacional de Saúde Doutor Ricardo Jorge, IP | pt_PT |
| dc.subject | Personalised Medicine | pt_PT |
| dc.subject | Familial Hypercholesterolemia | pt_PT |
| dc.subject | Doenças Cardio e Cérebro-vasculares | pt_PT |
| dc.title | Personalised medicine for Familial Hypercholesterolemia – pilot study | pt_PT |
| dc.type | conference object | |
| dspace.entity.type | Publication | |
| oaire.citation.conferencePlace | (online) | pt_PT |
| oaire.citation.title | 89th European Atherosclerosis Society Congress 2021, 30 maio - 2 junho 2021 | pt_PT |
| rcaap.rights | embargoedAccess | pt_PT |
| rcaap.type | conferenceObject | pt_PT |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Personalised medicine for Familial Hypercholesterolemia – pilot study.pdf
- Size:
- 338.67 KB
- Format:
- Adobe Portable Document Format